Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5282574
Max Phase: Preclinical
Molecular Formula: C35H40N4O7
Molecular Weight: 628.73
Associated Items:
ID: ALA5282574
Max Phase: Preclinical
Molecular Formula: C35H40N4O7
Molecular Weight: 628.73
Associated Items:
Canonical SMILES: COC(=O)C1=CNC(C)=C(C(=O)OC)C1c1cccc(Nc2c(NCCCN3CCC(c4cccc(OC)c4)CC3)c(=O)c2=O)c1
Standard InChI: InChI=1S/C35H40N4O7/c1-21-28(35(43)46-4)29(27(20-37-21)34(42)45-3)24-9-5-10-25(18-24)38-31-30(32(40)33(31)41)36-14-7-15-39-16-12-22(13-17-39)23-8-6-11-26(19-23)44-2/h5-6,8-11,18-20,22,29,36-38H,7,12-17H2,1-4H3
Standard InChI Key: QFMXASBYTCQRHY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 628.73 | Molecular Weight (Monoisotopic): 628.2897 | AlogP: 3.91 | #Rotatable Bonds: 12 |
Polar Surface Area: 135.30 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.28 | CX Basic pKa: 7.90 | CX LogP: 3.02 | CX LogD: 2.40 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.15 | Np Likeness Score: -0.58 |
1. Ronchetti R, Moroni G, Carotti A, Gioiello A, Camaioni E.. (2021) Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis., 12 (7.0): [PMID:34355177] [10.1039/D1MD00058F] |
Source(1):